Medpace Holdings, Inc. 4

President & CEO August J. Troendle sold 7,238 shares of Medpace Holdings, Inc. common stock for about $4.34 million at roughly $600 per share.

On July 27 and 28, 2026, Medpace Holdings, Inc. President & CEO August J. Troendle sold a total of 7,238 shares of Medpace Holdings common stock in open-market transactions executed via a limit order during an open trading window, at weighted average prices of approximately $600.85 and $600.01 per share, respectively, for aggregate proceeds of roughly $4.34 million. Following these sales, he directly owns 638,946 shares of common stock, and is also the sole manager and controlling unitholder of Medpace Investors, LLC, which holds an additional 4,733,019 shares that he may be deemed to beneficially own indirectly, though he disclaims beneficial ownership except to the extent of his pecuniary interest.

Filing Facts

CIK

1668397

Ticker

MEDP

Form

4

Source Type

fda

Accession

0001622058-26-000004

Alert Tier

7